Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE
6.1. Overview
6.2. Lung-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Heart-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Liver-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5. Intestine-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.6. Kidney-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.7. Skin-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.8. Blood-Brain Barrier-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.9. Human-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.10. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL ORGAN-ON-A-CHIP MARKET, BY APPLICATION
7.1. Overview
7.2. Drug Discovery
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Toxicology Research
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL ORGAN-ON-A-CHIP MARKET, BY ENDUSER
8.1. Overview
8.2. Pharmaceutical Companies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Research Organizations
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9. GLOBAL ORGAN-ON-A-CHIP MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Organ-on-a-Chip Market
10.5. Competitive Benchmarking
10.6. Leading Players in terms of Number of Developments in the Global Organ-on-a-Chip Market
10.7. Key Developments and Growth Strategies
10.7.1. Product Launch
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix & Market Ratio
10.8.1. Sales & Operating Income 2020
10.8.2. Major Players R&D Expenditure 2020
10.9. Major Players Capital Market Ratio
11. COMPANY PROFILES
11.1. CN Bio Innovations Limited
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Product Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Emulate
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Product Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. TissUse
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Product Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Mimetas
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Product Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Hµrel
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Product Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Nortis
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Product Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Insphero
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Product Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Tara Biosystems
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Product Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. AxoSim Technologies LLC
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Product Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Organovo
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Product Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. BioIVT
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Product Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. HemoShear
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Product Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports 
LIST OF TABLES
TABLE 1 GLOBAL ORGAN-ON-A-CHIP MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL ORGAN-ON-A-CHIP MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL ORGAN-ON-A-CHIP MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 10 US: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 11 US: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 12 US: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 13 CANADA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 14 CANADA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 15 CANADA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 16 LATIN AMERICA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 17 LATIN AMERICA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 18 LATIN AMERICA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 19 EUROPE: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 20 EUROPE: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 21 EUROPE: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ORGAN-ON-A-CHIP MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ORGAN-ON-A-CHIP MARKET
FIGURE 4 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE, BY ORGAN TYPE, 2020 (%)
FIGURE 5 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE, BY APPLICATION, 2020 (%)
FIGURE 6 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE BY ENDUSER,2020 (%)
FIGURE 6 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE, BY REGION, 2020 (%)
FIGURE 7 AMERICAS: ORGAN-ON-A-CHIP MARKET SHARE BY REGION, 2020 (%)
FIGURE 7 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 8 EUROPE: ORGAN-ON-A-CHIP MARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 11 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 GLOBAL ORGAN-ON-A-CHIP MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 13 CN BIO INNOVATIONS LIMITED.: KEY FINANCIALS
FIGURE 14 CN BIO INNOVATIONS LIMITED: SEGMENTAL REVENUE
FIGURE 15 CN BIO INNOVATIONS LIMITED: REGIONAL REVENUE
FIGURE 16 EMULATE: KEY FINANCIALS
FIGURE 17 EMULATE: SEGMENTAL REVENUE
FIGURE 18 EMULATE: REGIONAL REVENUE
FIGURE 19 TISSUSE: KEY FINANCIALS
FIGURE 20 TISSUSE: SEGMENTAL REVENUE
FIGURE 21 TISSUSE: REGIONAL REVENUE
FIGURE 22 MIMETAS: KEY FINANCIALS
FIGURE 23 MIMETAS: SEGMENTAL REVENUE
FIGURE 24 MIMETAS: REGIONAL REVENUE
FIGURE 25 HµREL: KEY FINANCIALS
FIGURE 26 HµREL: SEGMENTAL REVENUE
FIGURE 27 HµREL: REGIONAL REVENUE
FIGURE 28 NORTIS: KEY FINANCIALS
FIGURE 29 NORTIS: SEGMENTAL REVENUE
FIGURE 30 NORTIS: REGIONAL REVENUE
FIGURE 31 TARA BIOSYSTEMS: KEY FINANCIALS
FIGURE 32 TARA BIOSYSTEMS: SEGMENTAL REVENUE
FIGURE 33 TARA BIOSYSTEMS: REGIONAL REVENUE
FIGURE 34 INSPHERO: KEY FINANCIALS
FIGURE 35 INSPHERO: SEGMENTAL REVENUE
FIGURE 36 INSPHERO: REGIONAL REVENUE
FIGURE 37 AXOSIM TECHNOLOGIES LLC: KEY FINANCIALS
FIGURE 38 AXOSIM TECHNOLOGIES LLC: SEGMENTAL REVENUE
FIGURE 39 AXOSIM TECHNOLOGIES LLC: REGIONAL REVENUE
FIGURE 40 ASCENDANCE: KEY FINANCIALS
FIGURE 41 ASCENDANCE: SEGMENTAL REVENUE
FIGURE 42 ASCENDANCE: REGIONAL REVENUE
FIGURE 43 HEMOSHEAR: KEY FINANCIALS
FIGURE 44 HEMOSHEAR: SEGMENTAL REVENUE
FIGURE 45 HEMOSHEAR: REGIONAL REVENUE